home / stock / mdgl / mdgl quote
Last: | $271.67 |
---|---|
Change Percent: | 0.0% |
Open: | $273.81 |
Close: | $271.67 |
High: | $273.81 |
Low: | $268.6 |
Volume: | 77,460 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$271.67 | $273.81 | $271.67 | $273.81 | $268.6 | 77,460 | 07-04-2024 |
$271.67 | $273.81 | $271.67 | $273.81 | $268.6 | 77,460 | 07-03-2024 |
$271.67 | $279.41 | $271.67 | $282.54 | $271.44 | 179,633 | 07-02-2024 |
$279.31 | $277.02 | $279.31 | $282.37 | $276.87 | 290,253 | 07-01-2024 |
$280.16 | $285.07 | $280.16 | $286.467 | $277.72 | 861,402 | 06-28-2024 |
$285.66 | $275.37 | $285.66 | $288.25 | $270.5 | 252,964 | 06-27-2024 |
$275.36 | $279 | $275.36 | $279 | $267.51 | 293,946 | 06-26-2024 |
$280.04 | $283.56 | $280.04 | $285.7256 | $278.72 | 314,071 | 06-25-2024 |
$283.99 | $278.42 | $283.99 | $287 | $275.1949 | 372,179 | 06-24-2024 |
$278.42 | $267.09 | $278.42 | $280.59 | $266.97 | 586,651 | 06-21-2024 |
$267.79 | $273.38 | $267.79 | $273.38 | $260 | 407,025 | 06-20-2024 |
$276.01 | $276.88 | $276.01 | $279.26 | $273.28 | 308,468 | 06-19-2024 |
$276.01 | $276.88 | $276.01 | $279.26 | $273.28 | 308,468 | 06-18-2024 |
$276.72 | $275.82 | $276.72 | $285.61 | $275.01 | 315,350 | 06-17-2024 |
$277.59 | $275 | $277.59 | $280 | $268.07 | 418,093 | 06-14-2024 |
$277.02 | $285.83 | $277.02 | $288.755 | $276.12 | 415,205 | 06-13-2024 |
$285.83 | $291.49 | $285.83 | $295 | $280.33 | 840,192 | 06-12-2024 |
$291.99 | $254.43 | $291.99 | $295.5 | $252.665 | 1,570,747 | 06-11-2024 |
$254.88 | $243.18 | $254.88 | $255.44 | $238.78 | 483,991 | 06-10-2024 |
$244.34 | $235.02 | $244.34 | $245.105 | $227.78 | 467,573 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Madrigal Pharmaceuticals Inc. Company Name:
MDGL Stock Symbol:
NASDAQ Market:
Madrigal Pharmaceuticals Inc. Website:
2024-06-30 12:02:00 ET Madrigal Pharmaceuticals (NASDAQ: MDGL) is at a moment of great opportunity, and there's a decent chance that its shareholders will feel good about their investments over the next few years. After commercializing its first medicine, which treats a condition no...
2024-06-16 12:05:00 ET If you're eyeing an investment in Madrigal Pharmaceuticals (NASDAQ: MDGL) , now's the time to imagine a representative of Eli Lilly (NYSE: LLY) interrupting your train of thought by saying something along the lines of, "Not so fast." While the biotech ...
2024-06-15 09:45:00 ET Madrigal Pharmaceuticals (NASDAQ: MDGL) is in a position that most other biotechs envy. Its first medicine just hit the market, sales are due to start rolling in, and there aren't any other companies that can slow it down -- for now, that is. By mid-2027, ...